Research of the content of total saponins in commercially available Paris polyphylla from Wudang Mountain Area
HU Huaiming1,2 SHEN Ting3 YE Fang1,2 HUANG Liangyong1,2 LIANG Wenbin1,2
1.Department of Pharmacy, Shiyan City Taihe Hospital Affiliated to Hubei University of Medicine, Hubei Province, Shiyan 442000, China;
2.Engineering Research Center for Herbal Utilization of Hubei Province, Hubei University of Medicine, Hubei Province, Shiyan 442000, China;
3.College of Pharmacy, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430065, China
Abstract:Objective To compare the content of total saponins in commercially available Paris polyphylla from Wudang Mountain Area to investigate the quality of herbal pieces purchased from hospitals, pharmacies and other pharmaceutical markets. It provides a reference for production, distribution, clinical application and regulation of Paris polyphylla. Methods Herbal pieces of the Paris polyphylla were collected from hospitals and pharmacies in Wudang Mountain Area (mainly in Shiyan, Hubei Province). The content of total saponins in Paris polyphylla was determined by an ultraviolet-visible spectrophotometer at 406 nm with perchloric acid as chromogenic reagent. Results The content of saponins in Paris polyphylla from 23 samples had obvious differences, the minimum was 1.79%, and the maximum was up to 11.79%. Conclusion The quality of Paris polyphylla is unstable which can affect the safety and efficacy of clinical application. The supervision of the production and marketing of Paris polyphylla need to be strengthened. Only by promoting the standardized planting of Chinese medicine materials, the stable quality of Paris polyphylla can be ensured.
胡怀明1,2 沈婷3 叶方1,2 黄良永1,2 梁文斌1,2. 武当山区市售重楼饮片中总皂苷含量分析研究[J]. 中国医药导报, 2017, 14(30): 132-135.
HU Huaiming1,2 SHEN Ting3 YE Fang1,2 HUANG Liangyong1,2 LIANG Wenbin1,2. Research of the content of total saponins in commercially available Paris polyphylla from Wudang Mountain Area. 中国医药导报, 2017, 14(30): 132-135.
[1] 中国科学院中国植物志编辑委员会.中国植物志[M].北京:科学出版社,1978:86-96.
[2] 叶方,柳施一,胡培,等.武当山区重楼属植物基于ITS2的种内鉴别研究[J].中草药,2017,48(3):550-558.
[3] Zheng JY,Wang H,Chen XX,et al. Microsatellite markers for assessing genetic diversity of the medicinal plant Paris polyphylla var.chinensis(Trilliaceae) [J]. Genet Mol Res,2012,11(3):1975-1980.
[4] Song Y,Li MF,Xu J,et al. Polymorphic microsatellite markers in the traditional Chinese medicinal plant Paris polyphylla var.yunnanensis [J]. Genet Mol Res,2015,14(3):9939-9942.
[5] Li P,Fu JH,Wang JK,et al. Extract of Paris polyphylla Simth protects cardiomyocytes from anoxia-reoxia injury through inhibition of calcium overload [J]. Chin J Integr Med,2011,17(4):283-289.
[6] 年四辉,刘丽敏.重楼地上部分初步开发实验研究[J].云南中医中药杂志,2007,28(4):35-36.
[7] 钟月姣,刘莹,于新海,等.重楼活性成分及药理作用研究进展[J].黑龙江畜牧兽医,2016,2:69-71.
[8] Malla B,Gauchan DP,Chhetri RB. An ethnobotanical study of medicinal plants used by ethnic people in Parbat district of western Nepal [J]. J Ethnopharmacol,2015,165:103-117.
[9] 叶方,程镇,杨光义,等.重楼植物的栽培技术研究进展[J].中南药学,2015,13(11):1186-1189.
[10] 杨光义,胡培,叶方.重楼资源分布与可持续利用研究进展[J].中国药师,2016,19(1):159-162.
[11] 叶方,胡培,杨光义,等.湖北武当山地区重楼资源调查[J].中药材,2015,38(8):1616-1618.
[12] 国家药典委员会.中国药典[S].一部.北京:中国医药科技出版社,2015:260.
[13] 陈芳萍.中药质量影响中医临床疗效[J].海峡药学,2016, 28(3):197-198.
[14] 杨光义,叶方,郝新才.半仿生提取法在中药新药研究中的应用[J].中国药师,2010,13(8):1188-1190.
[15] 叶方,程镇,杨光义,等.紫外-可见分光光度法测定武当山区重楼属植物总皂苷的含量[J].中国药师,2015, 18(11):1983-1985.
[16] 卢伟,杨光义,叶方,等.正交试验设计优选重楼总皂苷提取工艺[J].中国药师,2015,18(9):1484-1487.
[17] 叶方,黄良永,陈黎,等.武当山区人工种植重楼中9种重楼皂苷含量分析[J].中南药学,2016,14(11):1244-1248.
[18] 杨光义,胡培,叶方,等.武当山区重楼属植物皂苷类成分含量比较[J].中南药学,2016,14(1):77-81.
[19] 吴建平,叶方,陈黎,等.武当山区栽培重楼根茎与须根中九种重楼皂苷含量比较[J].海南医学,2016,27(22):3613-3617.
[20] 杨金霞,张慧,叶方,等.武当山区不同采收期宽叶重楼地上部分总黄酮的累积规律[J].中国医药导报,2016, 13(24):16-20.